Prospective Study on the Efficacy and Safety of 2 Week or 3 Week Xelox Regimen for Adjuvant Chemotherapy in CRC
Clinical trial NCT03564912 · COMPLETED
Trial details
- NCT number
- NCT03564912
- Sponsor
- Zhejiang University
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-12
- Primary completion
- 2021-08-24
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.